Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIPP Study: Valganciclovir Prophylaxis vs Pre-emptive Therapy in Renal Transplant
NCT00372229Phase 3Completed
- Sponsor
- Roche
- Start
- May 2006
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Roche. Started May 2006; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00372229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372229.